Fiche centre
Wake Forest Baptist Medical Center
Winston-Salem — United States
Essais liés7clinical trials
VilleWinston-Salemlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07174414
Essais cliniques associés
7| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Non-Invasive Positive Pressure Ventilation | Maladie rénale chronique | Non applicable | NCT07558265 | WINDSURFER — WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department | RECRUITING |
| Impella 5.5 SmartAssist | Maladie coronarienne | Non applicable | NCT06965504 | INTeGRATE — INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery | RECRUITING |
| Active Colchicine | Maladie coronarienne | Phase 3 | NCT03310125 | Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF) | COMPLETED |
| Cilostazol 100 mg Tablets | Accident vasculaire cérébral | Phase 3 | NCT07174414 | Clarity — Cilostazol for Prevention of Recurrent Stroke Trial | NOT_YET_RECRUITING |
| TAK-935 | Épilepsie | Phase 2 | NCT03650452 | ELEKTRA — A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies | COMPLETED |
| BEAT-AD — Brain Energy for Amyloid Transformation in Alzheimer's Disease Study | Alzheimer | Non applicable | NCT03472664 | BEAT-AD — Brain Energy for Amyloid Transformation in Alzheimer's Disease Study | COMPLETED |
| Clemizole HCl | Épilepsie | Phase 3 | NCT04462770 | ARGUS — A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome | RECRUITING |